BRCA1/p220 Loss Triggers BRCA1-IRIS Overexpression via mRNA Stabilization in Breast Cancer Cells

Oncotarget - United States
doi 10.18632/oncotarget.462
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

BRCA1 Expression Modulates Chemosensitivity of BRCA1-defective HCC1937 Human Breast Cancer Cells

British Journal of Cancer
Cancer ResearchOncology
2003English

BRCA1-IRIS Inactivation Overcomes Paclitaxel Resistance in Triple Negative Breast Cancers

Breast Cancer Research
Cancer ResearchOncology
2015English

Breast Cancer 1 Early Onset (BRCA1)

Science-Business eXchange
2014English

Cisplatin in Breast Cancer Treatment in BRCA1 Carriers

Hereditary Cancer in Clinical Practice
OncologyGenetics
2012English

Somatic Loss of BRCA1 and P53 in Mice Induces Mammary Tumors With Features of Human BRCA1-mutated Basal-Like Breast Cancer

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2007English

Immunophenotypic Predictive Profiling of BRCA1-associated Breast Cancer

Virchows Archiv
MedicineForensic MedicinePathologyCell BiologyMolecular Biology
2010English

Resveratrol Increases BRCA1 and BRCA2 mRNA Expression in Breast Tumour Cell Lines

British Journal of Cancer
Cancer ResearchOncology
2003English

Neoadjuvant Therapy With Cisplatin in BRCA1-positive Breast Cancer Patients

Hereditary Cancer in Clinical Practice
OncologyGenetics
2011English

Risk Assessment for Hereditary Breast Cancer: BRCA1 and BRCA2

Canadian Oncology Nursing Journal
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy